Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma

NCT06829771

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Maanshan People's Hospital Ma’anshan, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 25 locations
View Trial Details
Recruiting

NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma

NCT07114367

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Catholic univ of Yeouido St Mary's Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

NCT04669171

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
  • University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details

Related conditions